Scienture Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Scienture Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $16 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 98% of Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $116 per $100 of sales comes from others' credit, against $1 tied up three years earlier. Less money tied up than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 97% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−$116Money owed to suppliers is larger than money owed by customers plus stock: $116 per $100 of sales comes from others' credit, against $1 tied up three years earlier.
Less money tied up than 98% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 96%
Sales fell 96% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-96% / +2169%In 3 years sales changed by -96% while total assets changed by +2169%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-554.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 97% of Healthcare companies in United States.
Cash Cushion Ratio
1.5× cashCash, after subtracting all debt, is 1.5 times its market value (net cash).
Higher than 93% of Healthcare companies in United States.
Tangible Assets Ratio
16%Of every $100 the company owns, $16 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 98% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 74% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Scienture Holdings, Inc. made a loss over the last year. Scienture Holdings, Inc. owes $0.27 for every $1 it owns. Scienture Holdings, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossScienture Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.07The share price is 0.07 times Scienture Holdings, Inc.'s book value per share, lower than almost all Healthcare companies in United States.
Market cap
$5 MThe total market value of all of Scienture Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 94% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$64 MWhat Scienture Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$39.03Net worth divided by the number of shares. The share price of $2.77 is 0.1 times this, which is the P/B above.
Return on equity (ROE)
-53.5%Scienture Holdings, Inc. lost 53.5% of its shareholders' money over the last year, lower than 53% of Healthcare companies in United States.
Owes vs Owns
0.27×Scienture Holdings, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Dividend yield
NoneScienture Holdings, Inc. does not currently pay a dividend.
Revenue growth
+216%Revenue rose 216% in the year to Dec 2025, and shrank 65% a year on average over 3 years.
Profit growth
LossScienture Holdings, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-9618.0%Scienture Holdings, Inc. lost $9618 for every $100 of revenue.
Interest cover
Not coveredScienture Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashScienture Holdings, Inc. held $7 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Scienture Holdings, Inc.: $5 M ÷ $64 M (30 Jun 2026) = 0.1.
What is Scienture Holdings, Inc.'s return on equity?
Scienture Holdings, Inc. lost 53.5% of its shareholders' money over the last year, lower than 53% of Healthcare companies in United States.
How much does Scienture Holdings, Inc. owe compared with what it owns?
Scienture Holdings, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Does Scienture Holdings, Inc. pay a dividend?
No. Scienture Holdings, Inc. does not currently pay a dividend.
Is Scienture Holdings, Inc.'s revenue growing?
Revenue rose 216% in the year to Dec 2025, and shrank 65% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.